We are live on ! Find out more
WCMNY

Westchester Capital Management (New York) Portfolio holdings

AUM $2.21B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+26.02%
3 Year Est. Return
+99.86%
5 Year Est. Return
+236.34%
10 Year Est. Return
+1,523.35%
AUM
$3.64B
AUM Growth
+$85.7M
Cap. Flow
-$35.8M
Cap. Flow %
-0.98%
Top 10 Hldgs %
32.26%
Holding
629
New
150
Increased
117
Reduced
17
Closed
182

Sector Composition

Rank Sector Weight
1 Financials 41.42%
2 Technology 12.77%
3 Healthcare 11.09%
4 Industrials 10.67%
5 Energy 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACDI
76
DELISTED
Ascendant Digital Acquisition Corp. III
ACDI
$10.2M 0.28%
986,336
+563,132
+133% +$5.76M
SHAP
77
DELISTED
Spree Acquisition Corp. 1 Limited
SHAP
$10.1M 0.28%
+989,234
New +$10.1M
CPAA
78
DELISTED
Conyers Park III Acquisition Corp. Class A Common Stock
CPAA
$10.1M 0.28%
1,024,698
+500,000
+95% +$4.9M
TIOA
79
DELISTED
Tio Tech A Class A Ordinary Share
TIOA
$10.1M 0.28%
995,805
+747,500
+301% +$7.47M
SVFB
80
DELISTED
SVF Investment Corp. 2 Class A Ordinary Shares
SVFB
$9.84M 0.27%
976,336
+437,881
+81% +$4.38M
CSTA
81
DELISTED
Constellation Acquisition Corp I
CSTA
$9.81M 0.27%
+970,238
New +$9.71M
GE icon
82
GE Aerospace
GE
$379B
$9.62M 0.26%
+184,265
New +$9.06M
GE icon
83
PUT
GE Aerospace
GE
$379B
$9.62M 0.26%
+184,265
New +$9.06M
DLCA
84
DELISTED
Deep Lake Capital Acquisition Corp. Class A Ordinary Shares
DLCA
$9.41M 0.26%
932,162
+363,498
+64% +$3.65M
VLAT
85
DELISTED
Valor Latitude Acquisition Corp. Class A Ordinary Shares
VLAT
$9.23M 0.25%
+917,866
New +$9.15M
TRTL
86
DELISTED
TortoiseEcofin Acquisition Corp. III
TRTL
$9.22M 0.25%
926,662
+146,429
+19% +$1.45M
GVCI
87
DELISTED
Green Visor Financial Technology Acquisition Corp. I Class A Ordinary Shares
GVCI
$9.16M 0.25%
883,495
+794,841
+897% +$8.14M
ALOR
88
DELISTED
ALSP Orchid Acquisition Corp I
ALOR
$9.08M 0.25%
886,610
+405,807
+84% +$4.12M
VVV icon
89
PUT
Valvoline
VVV
$4.25B
$9.05M 0.25%
+277,300
New +$8.39M
CLAA
90
DELISTED
Colonnade Acquisition Corp. II
CLAA
$8.94M 0.25%
887,751
+359,360
+68% +$3.59M
VALE icon
91
Vale
VALE
$61.4B
$8.91M 0.24%
+524,900
New +$7.89M
VALE icon
92
PUT
Vale
VALE
$61.4B
$8.91M 0.24%
+524,900
New +$7.89M
FAAS
93
DELISTED
DigiAsia
FAAS
$8.86M 0.24%
+862,104
New +$8.76M
LDTC
94
DELISTED
LeddarTech
LDTC
$8.85M 0.24%
1,752,830
+355,030
+25% +$1.78M
SCOB
95
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
$8.82M 0.24%
872,393
+649,032
+291% +$6.51M
THAC
96
DELISTED
Thrive Acquisition Corporation Class A ordinary shares
THAC
$8.68M 0.24%
839,833
+485,328
+137% +$4.97M
CPAR
97
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
$8.61M 0.24%
854,154
+289,285
+51% +$2.88M
COWN
98
DELISTED
Cowen Inc. Class A Common Stock
COWN
$8.39M 0.23%
217,286
UHG
99
DELISTED
United Homes Group
UHG
$8.35M 0.23%
830,112
BLUA
100
DELISTED
BlueRiver Acquisition Corp.
BLUA
$8.31M 0.23%
+824,191
New +$8.24M

Similar funds

Westchester Capital Management (New York)'s Q4 2022 Portfolio in Review

As of Q4 2022, Westchester Capital Management (New York) held 629 positions worth $3.64B, up 2.4% from $3.55B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Westchester Capital Management (New York)'s Q4 2022 filing shows 150 new, 117 increased, 17 reduced and 182 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $143M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 32% a quarter earlier, followed by Technology and Healthcare.

  • Westchester Capital Management (New York)'s largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M.
  • Westchester Capital Management (New York) added most to Signify Health, Inc. in Q4 2022, an estimated $49.6M increase.
  • Westchester Capital Management (New York)'s biggest Q4 2022 reduction was Silicon Motion, cutting an estimated $61.4M.
  • Westchester Capital Management (New York) fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $143M.
  • Westchester Capital Management (New York)'s ten largest holdings make up 32% of its $3.64B portfolio in Q4 2022.
  • Westchester Capital Management (New York) opened 150 new positions and closed 182 in Q4 2022.
  • Westchester Capital Management (New York)'s portfolio value rose 2.4% quarter-over-quarter to $3.64B.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.